4//SEC Filing
Investor Growth Capital, LLC 4
Accession 0000905718-18-000708
CIK 0001227636other
Filed
Aug 1, 8:00 PM ET
Accepted
Aug 2, 6:07 PM ET
Size
34.7 KB
Accession
0000905718-18-000708
Insider Transaction Report
Form 4
Investor Growth Capital, LLC
10% Owner
Transactions
- Conversion
Series D Convertible Preferred Stock
2018-07-02−339,342→ 0 total(indirect: See Footnote)→ Common Stock (339,342 underlying) - Conversion
Series E Convertible Preferred Stock
2018-07-02−206,380→ 0 total(indirect: See Footnote)→ Common Stock (206,380 underlying) - Conversion
Series F Convertible Preferred Stock
2018-07-02−515,953→ 0 total(indirect: See Footnote)→ Common Stock (515,953 underlying) - Conversion
Common Stock
2018-07-02+382,854→ 382,854 total(indirect: See Footnote) - Conversion
Common Stock
2018-07-02+124,987→ 507,841 total(indirect: See Footnote) - Conversion
Common Stock
2018-07-02+339,342→ 994,347 total(indirect: See Footnote) - Conversion
Common Stock
2018-07-02+515,953→ 1,716,680 total(indirect: See Footnote) - Conversion
Common Stock
2018-07-02+77,548→ 1,794,228 total(indirect: See Footnote) - Conversion
Common Stock
2018-07-02+206,380→ 1,200,727 total(indirect: See Footnote) - Conversion
Series A-2 Convertible Preferred Stock
2018-07-02−382,854→ 0 total(indirect: See Footnote)→ Common Stock (382,854 underlying) - Conversion
Series C Convertible Preferred Stock
2018-07-02−147,164→ 0 total(indirect: See Footnote)→ Common Stock (147,164 underlying) - Conversion
Series G Convertible Preferred Stock
2018-07-02−77,548→ 0 total(indirect: See Footnote)→ Common Stock (77,548 underlying) - Conversion
Common Stock
2018-07-02+147,164→ 655,005 total(indirect: See Footnote) - Conversion
Series B Convertible Preferred Stock
2018-07-02−124,987→ 0 total(indirect: See Footnote)→ Common Stock (124,987 underlying)
Footnotes (4)
- [F1]Each share of Convertible Preferred Stock as set forth in Table II above was convertible at any time, at the option of the holder, into shares of Neuronetics, Inc.'s (the "Issuer") Common Stock, on a one-for-one basis, has no expiration date, and will convert automatically into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration.
- [F2]Upon the conversion of the Convertible Preferred Stock as set forth in Table II, (i) 840,511 shares of Common Stock are held by Investor Growth Capital Limited ("Investor Limited"), (ii) 360,217 shares of Common Stock are held by Investor Group, L.P. ("Investor Group"), and (iii) 593,500 shares of Common Stock are held by IGC Fund VI, L.P. ("IGC Fund"). Investor Limited is a wholly-owned subsidiary of Investor Group; Investor Growth Capital, LLC ("Investor Growth") is the general partner of each of Investor Group and IGC Fund. Investor Growth is controlled by a Board of Directors consisting of Michael V. Oporto, Noah Walley, and Lennart Johansson. Investor Growth is deemed to share voting and investment power over the shares held by Investor Limited, Investor Group, and IGC Fund. The address of the foregoing entities is c/o Patricia Industries, 1177 Avenue of the Americas, 47th Floor, New York, New York 10036.
- [F3]An employee of an affiliate of Investor Growth, Mr. Stephen M. Campe is a member of the Issuer's Board of Directors. Mr. Campe may hold options to acquire Common Stock and, in addition, Mr. Campe may hold shares Common Stock, or other securities convertible into Common Stock. Mr. Campe separately files statements pursuant to Section 16 of the Securities Exchange Act of 1934 (the "Act") with respect to such options and securities. Pursuant to Rule 13d-4 under the Act, Investor Growth disclaims beneficial ownership of any of the Issuer's securities held by Mr. Campe. Moreover, Investor Growth disclaims group membership with Mr. Campe for the purposes of Section 13(d) of the Act, or for any other purpose.
- [F4]Investor Growth's interest in the Issuer's securities is limited to the extent of its pecuniary interest in such securities, if any, and neither the filing of this statement nor any of its contents shall be deemed to constitute an admission by Investor Growth, or any other person/entity, that he, she or it was or is the beneficial owner of any of the Company's securities for purposes of Section 16 of the Act, or for any other purpose.
Documents
Issuer
Neuronetics, Inc.
CIK 0001227636
Entity typeother
Related Parties
1- filerCIK 0001547569
Filing Metadata
- Form type
- 4
- Filed
- Aug 1, 8:00 PM ET
- Accepted
- Aug 2, 6:07 PM ET
- Size
- 34.7 KB